Traditional Chinese Medicine Combination for Lower-Dose Seizure Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antiepileptic drugs have limited efficacy for one-third of epilepsy patients and cause significant side effects, necessitating the development of safer and more effective treatments.
Innovation Solution
A traditional Chinese medicine composition comprising scutellaria root, heartleaf houttuymia, indigowoad root, mongolian snakegourd fruit, mulberry leaf, magnolia bark, peppermint herb, fineleaf nepeta, and baked liquorice root, which can be used alone or in combination with antiepileptic drugs like phenytoin, carbamazepine, lamotrigine, felbamate, benzodiazepines, tiagabine, and vigabatrin, to reduce drug dosage and side effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antiepileptic drugs (carbamazepine, phenytoin) are used to treat epilepsy, then seizure control is achieved, but significant side effects occur (hypersomnia, gastrointestinal disturbances, ataxia, blood disorders, hepatic insufficiency, arrhythmia, skin eruptions)
Solution Approach 1:
The patent combines multiple traditional Chinese medicine ingredients (Scutellaria baicalensis, Houttuynia cordata, Isatis indigotica, Trichosanthes kirilowii, Morus alba, Magnolia officinalis, Mentha haplocalyx, Nepeta tenuifolia, Saposhnikovia divaricata, Glycyrrhiza glabra) into a composite formulation NRICM101. This composite approach leverages synergistic effects of different herbal components to achieve antiepileptic efficacy while reducing the harmful side effects associated with conventional single-drug therapies.
Solution Approach 2:
The patent modifies the therapeutic parameter by using a multi-component herbal formulation instead of conventional chemical antiepileptic drugs. The complex phytochemical profile of NRICM101 (containing flavonoids, alkaloids, terpenoids, and other bioactive compounds) provides a different mechanism of action that achieves seizure control with a reduced side effect profile compared to conventional drugs.
2Object-generated harmful factors
If antiepileptic drug dosage is reduced to minimize side effects, then side effects are decreased, but epileptic recurrence increases causing patient suffering
Solution Approach 1:
The traditional Chinese medicine formulation NRICM101 acts as an intermediary therapeutic agent that can be used alone or in combination with conventional antiepileptic drugs. When used as an adjunct, it allows for reduction of conventional drug dosage while maintaining adequate seizure control, thus reducing side effects without compromising therapeutic reliability.
3Reliability
If conventional antiepileptic drugs are used, then seizure control is achieved, but approximately one-third of patients are resistant to existing medications
Solution Approach 1:
The patent employs a fundamentally different therapeutic approach using traditional Chinese medicine with a complex multi-component phytochemical profile. This alternative mechanism of action bypasses the drug resistance issues that affect one-third of patients with conventional antiepileptic drugs, providing efficacy for both drug-responsive and drug-resistant epilepsy cases.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present disclosure provides a traditional Chinese medicine combination for preventing or treating epileptic seizure and use in the preparation a medication. The traditional Chinese medicine combination has the characteristics of high efficiency, safety, and convenience and can effectively prevent or treat epileptic seizure while, and may be further combined with other anti-epileptic drugs to enhance the anti-epileptic effects and reduce medication side effects. The present disclosure also provides a method of preventing or treating epileptic seizure with the traditional Chinese medicine combination or a pharmaceutical combination.